Skip to main content

previous disabled Page of 2
and
Your search also matched 17 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

Include preview-only content
  1. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia

    In recent years, the development of adjunctive therapeutic hyperthermia for cancer therapy has received considerable attention. However, the mechanisms underlying hyperthermia resistance are still poorly under...

    Tao-Yan Lin, Jun-Shuang Jia, Wei-Ren Luo in Journal of Experimental & Clinical Cancer … (2024)

  3. Article

    Open Access

    High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA

    Normal high-density lipoprotein (nHDL) can induce angiogenesis in healthy individuals. However, HDL from patients with coronary artery disease undergoes various modifications, becomes dysfunctional (dHDL), and...

    Zhi-Wei Mo, Yue-Ming Peng, Yi-**n Zhang, Yan Li in Signal Transduction and Targeted Therapy (2023)

  4. Article

    Open Access

    Efficacy and safety of EGFR‑TKIs plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations

    The aim of this retrospective study is to evaluate the impact on efficacy and safety between epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) alone and in combination with Shenqi Fuzheng...

    Jia-li Wang, Chuan-sheng Chen, Zhi-rong Jia in Journal of Cancer Research and Clinical On… (2023)

  5. Article

    Open Access

    Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

    Pathologic complete response (pCR) following preoperative systemic therapy is associated with improved outcomes after subsequent liver transplant/resection in hepatocellular carcinoma (HCC). However, the relat...

    Cheng Huang, **ao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji in BMC Cancer (2023)

  6. Article

    Open Access

    Advancements in nanoparticle-based treatment approaches for skin cancer therapy

    Skin cancer has emerged as the fifth most commonly reported cancer in the world, causing a burden on global health and the economy. The enormously rising environmental changes, industrialization, and genetic m...

    Leli Zeng, B. H. Jaswanth Gowda, Mohammed Gulzar Ahmed in Molecular Cancer (2023)

  7. Article

    Open Access

    Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

    Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SAR...

    Huijie Bian, Zhao-Hui Zheng, Ding Wei in Signal Transduction and Targeted Therapy (2021)

  8. Article

    Open Access

    Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer

    Cisplatin is a first-line drug for the treatment of human non-small cell lung cancer (NSCLC); however, the majority of patients will develop drug resistance after treatment. In order to overcome cisplatin resi...

    Wen**g Wang, Mengyue Zhao, Lijuan Cui, Yong Ren, **gyuan Zhang in Molecular Cancer (2020)

  9. Article

    Open Access

    Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling

    Our previous study showed Musashi2 (MSI2) promoted chemotherapy resistance and pernicious biology of pancreatic cancer (PC) by down-regulating Numb and p53. We further explored the novel molecular mechanism in...

    Weiwei Sheng, **aoyang Shi, Yiheng Lin in Journal of Experimental & Clinical Cancer … (2020)

  10. Article

    Open Access

    Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

    Clinically, the median survival in patients with metastatic renal cell carcinoma (RCC) was only 6–12 months and a 5-year survival rate of less than 20%. Therefore, an in-depth study of the molecular mechanisms...

    Qian Zhu, Ai-Lin Zhong, Hao Hu, **g-**g Zhao in Journal of Hematology & Oncology (2020)

  11. Article

    Open Access

    CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling

    Angiogenesis plays critical roles in the progression and metastasis of malignant tumors. Gastric neuroendocrine carcinoma is an uncommon stomach cancer that is rich in blood vessels and exhibits highly maligna...

    Jian-**an Lin, **ong-Feng Weng, **n-Sheng **e, Ning-Zi Lian in Cancer Cell International (2019)

  12. Article

    Open Access

    Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma

    RING finger protein 38 (RNF38), a member of the RNF protein family, has just emerged as a vital driver of cancer progression. However, the oncogenic mechanisms of RNF38 remain unexplored.

    Rui Peng, Peng-Fei Zhang, Xuan Yang in Journal of Experimental & Clinical Cancer … (2019)

  13. Article

    Open Access

    PDXliver: a database of liver cancer patient derived xenograft mouse models

    Liver cancer is the second leading cause of cancer-related deaths and characterized by heterogeneity and drug resistance. Patient-derived xenograft (PDX) models have been widely used in cancer research because...

    Sheng He, Bo Hu, Chao Li, ** Lin, Wei-Guo Tang, Yun-Fan Sun in BMC Cancer (2018)

  14. Article

    Open Access

    Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

    To evaluate the prognostic significance of pretreatment quality of life for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

    Shan-Shan Guo, Wen Hu, Qiu-Yan Chen, Jian-Mei Li, Shi-Heng Zhu, Yan He in BMC Cancer (2018)

  15. Article

    Open Access

    Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion

    The communication between carcinoma associated fibroblasts (CAFs) and cancer cells facilitate tumor metastasis. In this study, we further underlying the epigenetic mechanisms of CAFs feed the cancer cells and ...

    Yu Ren, Huan-huan Jia, Yi-qi Xu, Xuan Zhou, **ao-hui Zhao, Yun-fei Wang in Molecular Cancer (2018)

  16. Article

    Open Access

    A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma

    Epstein-Barr virus (EBV) commonly infects the general population and has been associated with nasopharyngeal carcinoma (NPC), which has a high incidence in certain regions. This study aimed to address how EBV ...

    Fu-Tuo Feng, Qian Cui, Wen-Sheng Liu, Yun-Miao Guo in Chinese Journal of Cancer (2015)

  17. Article

    Open Access

    The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy

    The impact of cumulative dose of cisplatin on clinical outcomes of nasopharyngeal carcinoma (NPC) patients who received intensity-modulated radiotherapy (IMRT) was evaluated.

    Shan-Shan Guo, Lin-Quan Tang, Lu Zhang, Qiu-Yan Chen, Li-Ting Liu, Ling Guo in BMC Cancer (2015)

  18. Article

    Open Access

    Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments

    The mouse is an organism that is widely used as a mammalian model for studying human physiology or disease, and the development of immunodeficient mice has provided a valuable tool for basic and applied human ...

    Wei Ye, Zhiwu Jiang, Guan-**ong Li, Yiren **ao in Journal of Hematology & Oncology (2015)

  19. Article

    Open Access

    High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma

    Talin-1 is a cytoskeletal protein that plays an important role in tumourgenesis, migration and metastasis in several malignant tumors. The aim of this study was to evaluate the expression and prognostic value ...

    Ya-Fei Xu, **an-Yue Ren, Ying-Qin Li, Qing-Mei He, **n-Ran Tang, Ying Sun in BMC Cancer (2015)

  20. Article

    Corrigendum: Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54

    Nat. Genet. 42, 759–763 (2010); published online 22 August 2010; corrected after print 27 August 2014 In contrast to the version of this article initially published, the authors now find no evidence to support...

    Li-Dong Wang, Fu-You Zhou, Xue-Min Li, Liang-Dan Sun, **n Song, Yan ** in Nature Genetics (2014)

previous disabled Page of 2